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Abstract GDP-D-mannose dehydratase (GMD) catalyzes the 
first step of the pathway that converts GDP-D-mannose to GDP-
L-fucose in bacteria, plants and mammals. Recently, the gene 
coding for GMD has been identified and sequenced in E. coli. 
Based on this sequence, we have expressed and purified GMD in 
E. coli as a glutathione transferase (GST) fusion protein. The 
fused GST-GMD protein and the thrombin-cleaved GMD were 
then characterized. The catalytically active form of both enzyme 
species seems to be a hexamer of 410 and 250 kDa, respectively. 
The GST-GMD fusion protein has a Km of 0.22 ± 0.04 mM and 
a specific activity of 2.3 ±0.2 /ffliol/h/mg. Ca2+ and Mg2+ 
activate GMD, while GDP-L-j3-fucose, the end-product of the 
pathway, inhibits it specifically. The GST-GMD fusion protein 
contains one mole of tightly bound NADP+ per mole of hexamer. 
Apparently, this NADP+ is involved in the catalytic mechanism 
of GMD. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
L-Fucose is a 6-deoxy-monosaccharide widely occurring in 
glycoconjugates from many different sources, from microor-
ganisms to plants and animals. L-Fucose is formed from 
GDP-D-mannose via a metabolic pathway identified by Gins-
burg both in bacteria and animal tissues [1-3], which leads to 
the formation of GDP-L-(3-fucose. This latter compound is the 
substrate for many different fucosyltransferases, that are re-
sponsible for the incorporation of L-fucose in glycoproteins 
and glycolipids [4,5]. 
The first step of this metabolic pathway is believed to be the 
dehydration of GDP-D-mannose, with the formation of the 
quite unstable intermediate GDP-4-keto-6-deoxy-D-mannose 
[1-3,6-8]. The second part of the pathway consists of an epi-
merization at C-3 and C-5 followed by an NADPH-dependent 
reduction of the 4-keto group, leading to GDP-L-fucose for-
mation [9]. We have recently isolated and sequenced the en-
zyme, formerly named FX [10,11], which is responsible for the 
second part of this pathway in human cells and which displays 
both the epimerase and the reductase activities [12]. 
The enzyme catalyzing the first reaction, i.e. GDP-D-man-
nose 4,6-dehydratase (EC 4.2.1.47) (GMD), has been obtained 
to different degrees of purity from both bacteria and mam-
mals [6,13]. The mechanism of the GMD-catalyzed reaction 
has been proposed to involve a protein-bound pyridine dinu-
cleotide as responsible for the transfer of C-4 hydrogen to the 
C-6 position of the deoxy-monosaccharide [1,6], similarly to 
what has been demonstrated for the TDP-D-glucose dehydra-
tase involved in TDP-L-rhamnose synthesis in bacteria [14]. 
NAD+ was postulated to play this role with the GMD puri-
fied from porcine thyroid [6], while NADP+ has been more 
recently implicated with the Klebsiella pneumoniae enzyme 
[13]. Another apparent difference concerning GMD purified 
from the two above sources is its oligomeric structure, re-
ported to be hexameric for the thyroid enzyme [6] and dimeric 
for the K. pneumoniae protein [13]. 
The nucleotide sequence of the gene coding for GMD and 
the amino acid sequence of GMD protein have not yet been 
identified. A putative sequence of GDP-D-mannose 4,6-dehy-
dratase in E. coli, named orfO.0, was proposed on the basis of 
its close relationship to sequences found in gene clusters re-
sponsible for other metabolic pathways (i.e. colitose and per-
osamine synthesis), in which GMD activity is involved [15]. 
Recently, Stevenson et al. [16] demonstrated that the gmd 
gene, corresponding to orfO.0, which is contained in the E. 
coli K12 wca gene cluster responsible for colanic acid produc-
tion, once cloned in a vec«-deleted strain, is able to restore 
GMD activity in the crude lysate from the deficient cells. 
This finding strongly supported the identification of the pre-
viously proposed sequence. However, the molecular and en-
zymatic properties of the E. coli GMD are so far completely 
unknown. 
In this paper we report the expression of GMD in E. coli as 
GST-fusion protein and its structural and enzymatic charac-
terization. Our results, which confirmed the enzymatic activity 
of the gmd gene product and demonstrated the presence of 
tightly protein-bound NADP+, should allow the complete in 
vitro reconstruction of the pathway from GDP-D-mannose to 
GDP-L-fucose and accordingly the elucidation of its kinetic 
and regulatory properties. 
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2. Materials and methods 
2.1. Expression and purification of recombinant GDP-D-mannose 
4,6-dehydratase (GMD) 
Chromosomal DNA was prepared from E. coli (strain INVF1, In-
vitrogen) as described [17]. The following primers, used to amplify the 
gmd gene, were designed on the basis of the sequence reported by 
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Stevenson et al. [16] (GenBank accession no. U38473) and were ob-
tained from TibMolBiol, Genova, Italy: 
5'-AATTAGATCTATGTCAAAAGTCGCTCTCATCACC (for-
ward) 
5'-AATTCTCGAGTTATGACTCCAGCGCGATCGCC (reverse). 
Three ug of chromosomal DNA were amplified with the following 
PCR conditions: 94°C for 30 s, 64°C for 30 s, 72°C for 75 s for 15 
cycles, 1.5 mM MgCi2. For protein expression the Glutathione-S-
Transferase (GST) Gene Fusion System (Pharmacia, Milan, Italy) 
was used. The 1134 base-pair PCR product was digested with Bglll 
and Xhol restriction enzymes (Amersham, Milan, Italy) and ligated 
into BamHl and Xhol sites of pGEX-4T-2 plasmid (Pharmacia), 
which contains a region coding for the thrombin protease recognition 
site, using standard protocols [17]. This plasmid was chosen because 
no thrombin cleavage sites were present on the GMD sequence. After 
ligation, the plasmid was transfected into E. coli for protein expres-
sion. The plasmids obtained from single colonies were then sequenced 
using Sequenase 2.0 (Amersham) to verify the presence of the correct 
insert. E. coli cells were then grown overnight in LB broth [17] at 
37°C. The overnight culture was diluted 1 : 20 in LB and grown at 
25°C to reach an optical density of 0.6 at 660 nm. The cells were then 
induced for 18 h with 0.1 mM IPTG at 25°C. 
Cells were collected by centrifugation, washed with ice-cold H2O 
and then lysed by sonication in 100 mM Tris-HCl, pH 8.3, containing 
150 mM NaCl, 1% Triton X-100, 2 mg/ml lysozyme, 3 mM PMSF, 
5 |Xg/ml aprotinin, 10 ug/ml soybean trypsin inhibitor, 5 ug/ml leu-
peptin, 10 mM EDTA (all from Sigma, Milan, Italy). The crude ex-
tract was clarified by centrifugation at lOOOOXg for 10 min. 
The GST-GMD fused protein was purified from the supernatant 
by affinity chromatography, using GST-Sepharose-4B (Pharmacia) 
and following the manufacturer's instructions. GST-GMD fused 
protein was eluted directly from half of the GST-Sepharose using 
10 mM GSH at 25°C. The remaining matrix with the bound 
fusion protein was treated with 50 U/ml thrombin (Pharmacia), 
which recognizes a cleavage sequence inserted between GST and 
GMD, for 16 h at 25°C. This treatment released the native GMD, 
while GST remained bound to the matrix. Thrombin was then re-
moved from the eluate by treatment with benzamidine-Sepharose-6B 
(Pharmacia). 
2.2. Characterization of recombinant GMD 
The recombinant proteins were analyzed by discontinuous SDS-
PAGE [18] in order to check purity and molecular mass. Size exclu-
sion chromatography was performed on an HP 1090 HPLC sys-
tem (Hewlett Packard, Walbronn, Germany) with a TSK-gel 
G3000SWXL column (5 urn particle size, 7.8x300 mm, TosoHaas, 
Montogomeryville, PA, USA), mobile phase 0.1 M sodium phosphate 
buffer, pH 7.5, containing 0.1 M Na2SC"4, at a flow rate of 0.7 ml/min. 
Molecular mass markers for denaturing gel electrophoresis and for 
size exclusion chromatography were obtained form Sigma. 
2.3. Enzyme assays 
Both the GST-GMD fusion protein and the thrombin-cleaved 
GMD were analyzed for the ability to convert GDP-D-mannose (Sig-
ma) to GDP-4-keto-6-deoxy-D-mannose. The standard assay was per-
formed at 37°C in 50 mM Tris-HCl buffer, pH 8.0, with 1 mM MgCl2 
(unless otherwise specified), using different concentrations of GDP-D-
mannose containing GDP-D-[U-14C]mannose (Amersham) with a final 
specific activity of 6.2 mCi/mmol. The reaction mixture was depro-
teinized and the identity of the GMD product, i.e. GDP-4-keto-6-
deoxy-D-mannose, was evaluated both by HPLC analysis, using a 
Packard Flow-One detector for radioactivity, and by TLC analysis, 
after NaBH4 reduction and acid hydrolysis, as previously de-
scribed^]. Protein concentration was determined according to Brad-
ford [19]. 
The amount of NAD+ or NADP+ bound to the GST-GMD fused 
protein was determined by a sensitive enzymatic cycling assay proce-
dure [20], using ethanol and alcohol dehydrogenase for NAD + anal-
ysis and glucose 6-P and glucose 6-P dehydrogenase for NADP+ , 
respectively. All the reagents used for these assays were obtained 
from Sigma. Before performing the analyses, the protein was exten-
sively dialyzed to remove any trace of residual GSH, which proved to 
interfere with the colorimetric assay. 
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3. Results 
Approximately as much as 15 mg of the GST-GMD fusion 
protein could be obtained from 1 liter of E. coli culture. The 
induction for longer periods of time at lower temperature and 
IPTG concentration (see Section 2.1), compared to standards 
protocols [17], was essential to avoid precipitation of the fused 
protein inside the cells and to obtain a functional enzyme. 
After affinity purification using GST-Sepharose, the fusion 
protein migrated as a single band with an apparent molecular 
mass of 68 kDa (Fig. 1, lane 2), consistent with the sum of the 
molecular masses of GST and GMD, as predicted by trans-
lation of the corresponding nucleotide sequences. Thrombin 
cleavage of the matrix-bound GST-fusion protein and subse-
quent removal of thrombin by treatment with benzamidine-
Sepharose produced a single band of approximately 42 kDa 
(Fig. 1, lane 1), which is in agreement with the expected Mx 
for the native GMD and compares well with the Mr of the 
porcine thyroid enzyme [6]. 
Gel permeation analysis was used to determine the native 
molecular mass of both the GST-fused and the cleaved GMD. 
As shown in Fig. 2A, HPLC size exclusion chromatography 
of the GST-fused GMD yielded three distinct peaks. Compar-
ison of the elution volumes of these peaks with those of 
known molecular weight standards suggested the presence of 
a hexameric structure (expected Mr, 410 kDa), of a trimer 
(205 kDa) and of the single monomer corresponding to the 
GST-GMD fusion protein (68.4 kDa), respectively. Out of the 
three peaks, only peak 1 (see Fig. 2A) exhibited enzymatic 
activity, while the other two were catalytically inactive, nor 
did they regain activity upon supplying NADP+ or NAD+ to 
the corresponding fractions. After thrombin cleavage, size ex-
clusion HPLC chromatography revealed the presence of two 
peaks, with apparent molecular weights of 250 and 130 kDa, 
respectively, again suggesting the presence of a hexameric and 
of a trimeric structure deriving from the 42 kDa monomer 
(Fig. 2B). Similarly to the findings obtained with the GMD-
fusion protein, enzymatic activity was observed in peak 1 
only. 
Both the GST-fusion protein and the thrombin-cleaved 
GMD exhibited enzymatic activity, converting GDP-D-man-
Fig. 1. SDS-PAGE analysis [18] of the thrombin-cleaved GMD 
(lane 1) and of GST-GMD fusion protein after purification on 
GST-Sepharose (lane 2). Five u,g of protein were loaded and the gel 
was stained with Coomassie Brilliant Blue R-250. 
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Fig. 2. Size exclusion chromatography, performed against known molecular weight standards, of purified GST-GMD fused protein (A) and of 
the thrombin-cleaved GMD (B). Molecular mass standards: urease (hexameric form), 540 kDa; ferritin, 450 kDa; urease (trimeric form), 270 
kDa; bovine serum albumin, 68 kDa. 
nose to GDP-4-keto-6-deoxy-D-mannose, as determined by 
HPLC and TLC analyses [12]. The instability of the throm-
bin-cleaved GMD, which was not prevented by addition of 
thiol compounds, antioxidants or chelating agents (see Section 
4), prompted us to study the functional activity of the GST-
fusion protein, which could be assayed immediately after pu-
rification from GST-Sepharose and which proved to be 
mainly in the hexameric form by size exclusion HPLC analysis 
(Fig. 2A). The Km, determined in 50 mM Tris-HCl, pH 8.0, in 
the presence of 1 mM MgCl2, was 222 ±44 uM and the spe-
cific activity was 2.3 ±0.2 urnol/h/mg protein. The GST-fused 
GMD exhibited a pH optimum at 8.0 (Fig. 3A) and was 
remarkably stimulated by both MgCl2 and CaCl2, as shown 
in Fig. 3B. 
GMD has been previously reported to require NAD+ as 
cofactor for an internal oxido-reduction reaction between C-
4 and C-6 of the GDP-bound sugar [6]. Conversely, GMD 
purified from K. pneumoniae has been shown to have a strict 
requirement of exogenous NADP+ for activity [13]. In our 
system, the activity of the recombinant E. coli protein, both 
as GST-fused and cleaved GMD, was unaffected by the addi-
tion of exogenous NAD+ or NADP+. However, the cycling 
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Fig. 3. (A) Effect of pH on the activity of GST-GMD fused protein. Data are expressed as relative activity, assigning a value of 100 to the 
maximal activity observed (see Section 2.3). (B) Activity of GST-GMD fused protein in the presence of different concentrations of divalent cati-
ons. A value of 1 was assigned to the activity observed in the absence of both Ca2+ and Mg2+. 
assays indicated that NADP+ , and not NAD + , is firmly 
bound to the protein. The molar ratio of NADP+/GST-
GMD fusion protein obtained with this sensitive assay proce-
dure was 1.18 ±0.24, suggesting that one molecule of the di-
nucleotide is bound to one molecule of native hexamer. No 
NADP+ was found when the catalytically inactive protein 
(obtained after prolonged storage at 25°C), was analyzed, 
supporting the view of a strict requirement of tightly bound 
NADP+ for the mechanism of the enzymatic reaction. 
GMD purified from porcine thyroid was reported to be 
susceptible to inhibition by GDP-L-P-fucose [6]. Table 1 re-
ports the effects of this and other GDP-monosaccharides on 
GST-GMD fused protein activity. GDP-L-P-fucose, which is 
the terminal product of this metabolic pathway, showed a 
significant inhibitory activity, while GDP-L-oc-fucose had no 
effect, thus suggesting a specific mechanism of feedback inhib-
ition. A low extent of inhibition was also observed with GDP-
D-glucose, while GDP alone was ineffective. 
4. Discussion 
The metabolic pathway from GDP-D-mannose to GDP-L-
fucose, initially identified and partially characterized by Gins-
burg in the sixties [1-3], is remarkably conserved in the evo-
Table 1 
Effects of GDP-monosaccharides on GST-fused GMD activity 
Concentration (uM) % Inhibition 
Control (no inhibitor) 
GDP-L-|3-fucose 
GDP-L-a-fucose 
GDP-D-glucose 
GDP 
10 
100 
250 
10 
100 
250 
100 
250 
500 
100 
250 
500 
0 
0 
54 ±15 
73±4 
0 
0 
0 
0 
11 ±4 
34 ±12 
0 
0 
0 
GST-GMD fusion protein was incubated for 15 min with 10 itM 
GDP-D-mannose in 50 mM Tris-HCl, pH 8.0 and 1 mM MgCl2 in 
the presence of different concentrations of guanine nucleotides. Re-
sults are expressed as percent of inhibition compared to the control 
incubated in the absence of inhibitors. 
lution. This fact emphasizes its importance for the biosynthe-
sis of GDP-L-fucose which in mammalian cells can be formed, 
although to a comparably much lower extent, also by a 'sal-
vage' pathway from GTP and L-fucose 1-P [21,22]. 
Some uncertainties still remain on the properties of the 
GDP-D-mannose to GDP-L-fucose pathway. Although 
GMD has been purified from both bacterial and animal sour-
ces, the nucleotide or amino acid sequences have never been 
determined. A putative nucleotide sequence has been postu-
lated for the E. coli GMD, but only recently did it receive a 
biochemical validation [16]. Our data provide final evidence 
that the product of the gmd gene is indeed GDP-D-mannose 
4,6-dehydratase and supply further insight on the molecular 
and functional properties of this enzyme. Furthermore, the 
present results allow large amounts of enzyme to be obtained, 
compared to the quite lower quantities available upon purifi-
cation from porcine thyroid [6], from K. pneumoniae [13] and 
from bovine and human tissues (Tonetti, M. and Sturla, L., 
unpublished data). Thus, it will be possible to scale up the 
preparation of its enzymatic product, the GDP-4-keto-6-de-
oxy-D-mannose, a very labile intermediate, which is the sub-
strate of the second enzyme (FX) involved in the pathway 
form GDP-D-mannose to GDP-L-fucose. This should lead to 
a more detailed characterization of the epimerase-reductase 
activity displayed by FX protein. In particular, the availability 
of both enzyme proteins involved in the pathway, i.e. the ex-
pressed GMD and the purified FX protein [12], makes it 
possible for the first time to reconstruct this pathway in vitro 
and to identify discrete mechanisms of reaction and specific 
sites of regulation (see below). For instance, the established 
presence of tightly GMD-bound NADP+, coupled with the 
known NADPH requirement of the epimerase/reductase that 
catalyzes the formation of the end-product (and feedback in-
hibitor) GDP-L-fucose, seems to suggest a key role of the 
cellular NADP+/NADPH redox system in the regulation of 
the complete pathway. In any case, the occurrence of tightly 
apoenzyme-bound NADP+ playing both a structural and a 
catalytic role is strongly reminiscent of the long known prop-
erty previously established for human erythrocyte glucose 6-P 
dehydrogenase [23,24]. 
The finding that NADP+ is the cofactor essential for GMD 
activity is in contrast with the generally accepted notion which 
considers NAD+ to be involved in the reaction, by analogy 
with TDP-D-glucose 4,6-dehydratase and CDP-D-glucose 4,6-
130 L. Sturla et al.lFEBS Letters 412 (1997) 126-130 
dehydratase [14,25]. Our results are partially in agreement 
with the data obtained for G M D purified from K. pneumo-
niae, which requires the exogenous addition of N A D P + [13]. 
This enzyme, however, seems to be structurally different from 
the E. coli G M D , since it was reported to be a dimer com-
posed by two identical subunits of 55 kDa, while the recombi-
nant protein and also G M D purified from porcine thyroid 
were found to be hexamers [6]. 
Attention is being paid to elucidate the structural basis of 
the instability of enzymatic activity of the thrombin-cleaved 
G M D . This rapid inactivation is in agreement with the results 
reported by Broschat et al. [6] on the lability of G M D during 
purification from porcine thyroid and with our data on the 
poor stability of both human erythrocyte and bovine pancre-
atic G M D at different degrees of purification (Tonetti, M. and 
Sturla, L., unpublished data). Notwithstanding this problem, 
which might underlie specific regulatory mechanisms of G M D 
activity, the present characterization of the G S T - G M D fusion 
protein seems to provide useful information on the native 
enzyme, similarly to other fusion proteins generated and 
used to investigate the catalytic properties [26] and the sub-
cellular compartmentalization [27] of specific enzymes. Com-
plete reconstruction of a species-homologous pathway from 
GDP-D-mannose to GDP-L-fucose would be more informative 
than studies on heterologous enzyme proteins. To this pur-
pose and to complete the present data, expression in E. coli of 
the previously sequenced wcaG gene [15], which shows a re-
markably high sequence homology with F X protein, i.e. the 
epimerase/reductase activity that catalyzes GDP-L-fucose syn-
thesis, is currently underway in our laboratory. 
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